Top Markets
Coin of the day
Actuate Therapeutics Inc Actuate Therapeutics Inc

Actuate Therapeutics Inc

ACTU
Ранг среди акций #28698
Actuate Therapeutics, Inc. is a biopharmaceutical firm operating at the... Actuate Therapeutics, Inc. is a biopharmaceutical firm operating at the clinical stage, dedicated to creating treatments for various cancers. Its primary drug candidate is Elraglusib Injection, an innovative glycogen synthase kinase-3 (GSK-3) inhibitor designed to combat metastatic pancreatic ductal adenocarcinoma. Furthermore, Elraglusib is being developed to address other malignancies, including Ewing sarcoma, metastatic melanoma, and colorectal cancer. Originally named Apotheca Therapeutics, Inc., the organization rebranded as Actuate Therapeutics, Inc. in October 2015. Established in 2015, the company maintains its headquarters in Fort Worth, Texas.
Цена акции
$1.05
Последняя синхронизация: 2026-08-19
Рыночная капитализация
$25.12M
Изменение (1 день)
0.00%
Изменение (1 год)
-86.33%
Страна
US
Торговля Actuate Therapeutics Inc (ACTU)

Категория

История цены акций Actuate Therapeutics Inc (ACTU)
Наивысшая цена закрытия: $1.04 2026-08-01

Наименьшая цена закрытия: $8.39 2024-08-01
История цены акций Actuate Therapeutics Inc с 2024 по 2026
Годовая динамика цены акций
Год Результативность
2026 (TTM) -36.60%
2025 -14.02%
2024 0.00%
Цена акций похожих компаний или конкурентов
Компания Цена акций Изменение 1г% Страна
$552.07 39.99%
US
$168.77 527.63%
US
$1.03K 56.22%
NL
$121.05 -14.77%
AU
$753.28 5.84%
CH